Treatment for Recurrent Pericarditis
The recommended treatment for recurrent pericarditis is a stepwise approach starting with NSAIDs (preferably ibuprofen) plus colchicine as first-line therapy, followed by corticosteroids as second-line therapy, and then consideration of immunosuppressants (azathioprine), IVIG, or IL-1 blockers (anakinra, rilonacept) for refractory cases, with pericardiectomy as a last resort for treatment-resistant cases. 1, 2, 3
First-Line Treatment
- NSAIDs plus colchicine:
- Ibuprofen 300-800mg every 6-8 hours (preferred for its favorable coronary flow impact and wide dose range) 1
- Aspirin can be used as an alternative (except in children due to risk of Reye's syndrome) 4
- Colchicine 0.5mg twice daily in addition to NSAIDs 1, 2
- Continue treatment until complete symptom resolution and normalization of inflammatory markers (CRP) 5
- Colchicine should be continued for at least 6 months for recurrent cases 6
Clinical Pearl: Gastrointestinal protection must be provided with NSAID therapy to prevent complications 1.
Second-Line Treatment
- Corticosteroids (when NSAIDs/colchicine are contraindicated or ineffective):
Important: Corticosteroids should not be used as first-line therapy due to increased risk of recurrence with their use 3.
Third-Line Treatments for Refractory Cases
For the approximately 5% of patients who develop corticosteroid-dependence and colchicine resistance 2:
- Azathioprine as an immunosuppressant option 2, 4
- Intravenous immunoglobulin (IVIG) 2, 4
- IL-1 blockers (anakinra, rilonacept, goflikicept) - particularly effective for patients who cannot be weaned off corticosteroids 3
Last Resort
- Pericardiectomy (surgical removal of the pericardium) for cases refractory to all medical therapy 2, 4
- Should be performed only in experienced centers 2
Monitoring and Follow-up
- Regular monitoring of CRP levels to guide treatment duration 5
- Echocardiographic assessment to evaluate pericardial thickness and ventricular filling patterns 5
- Physical activity restriction beyond ordinary sedentary life until symptoms resolve and CRP normalizes (minimum 3 months for athletes) 5
- Tapering should begin only after CRP normalization and symptom resolution 5
Special Considerations
Pregnancy: Aspirin (low-moderate doses) preferred during first and second trimesters; NSAIDs may be used until gestational week 20; prednisone at lowest effective doses may be used throughout pregnancy with calcium and vitamin D supplementation 5
Children: Colchicine dosing 5:
- <5 years: 0.5mg/day
5 years: 1.0-1.5mg/day in 2-3 divided doses
Prognosis
Despite significant impairment of quality of life, most common forms of recurrent pericarditis have good long-term outcomes with negligible risk of developing constrictive pericarditis and rarely cardiac tamponade during follow-up 4.